comparemela.com
  1. Home
  2. Live Updates
  3. Aromatase Inhibitor Resistant Hormone - Breaking News

Latest Breaking News On - Aromatase inhibitor resistant hormone - Page 1 : comparemela.com

Capivasertib and Fulvestrant for Patients with Aromatase Inhibitor-resistant Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2-negative Advanced Breast Cancer: Results from the Phase III CAPItello-291 Trial

Hope Rugo, MD reviews key data from the CAPItello-291 phase 3 trial recently presented at the San Antonio Breast Cancer Symposium in December 2022.

Aromatase inhibitor resistant hormoneHuman epidermal growth factor receptorAdvanced breast cancerBreast cancerHr breast cancerHer2 breast cancerCapitello trialCapitello 291Jcdk4 6 inhibitorPik3ca alterationAkt1 alterationPten alterationCapivasertib adverse eventsAdverse eventsFulvestrant capivasertibFulvestrant adverse events

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.